GENinCode Plc
Research GENinCode Plc (GENI.L) on Bullrun: market cap GBX 386.14M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGENI.L
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyGBX
- Market capGBX 386.14M
- Financial periodFY2025
- RevenueGBP 3.08M
- Revenue growth13.9%
- Net income-GBP 5.71M
- Free cash flow-GBP 4.17M
- Gross margin58.6%
Valuation Snapshot
latest market cap is GBX 386.14M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 3.08M | -GBP 5.71M | -GBP 4.17M | 58.6% | -0.02 | GBP 827.00K | GBP 146.00K | GBP 124.00K |
| FY2024 | GBP 2.70M | -GBP 4.43M | -GBP 5.22M | 52.8% | -0.03 | GBP 1.11M | GBP 234.00K | GBP 1.13M |
| FY2023 | GBP 2.16M | -GBP 7.02M | -GBP 7.54M | 47.3% | -0.07 | GBP 2.48M | GBP 299.00K | GBP 1.29M |
| FY2022 | GBP 1.43M | -GBP 5.56M | -GBP 4.57M | 44.2% | -0.06 | GBP 9.73M | GBP 354.00K | GBP 7.90M |
| FY2021 | GBP 1.15M | -GBP 4.14M | -GBP 3.24M | 51.4% | -0.08 | GBP 14.55M | GBP 0 | GBP 13.72M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-30 | GBX 386.14M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About GENinCode Plc
GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient's health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally. The company offers CARDIO inCode Score, a genetic test to evaluate the risk of coronary heart disease; LIPID inCode, a genetic test for the diagnosis of familial hypercholesterolemia with further coronary risk stratification of the patient;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GENinCode Plc's market cap?
GENinCode Plc's market capitalization is GBX 386.14M.
What does GENinCode Plc do?
GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient's health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally.